Latest News and Press Releases
Want to stay updated on the latest news?
-
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable...
-
Sanoman Q1 2026 osavuosikatsaus julkaistiin 7.5.2026
-
Sanoma's Q1 2026 Interim Report was published on 7 May.
-
Magnite Reports First Quarter 2026 Results
-
Sanoma julkaisee Q1 2026 osavuosikatsauksensa 7.5.2026
-
Sanoma will publish its Q1 2026 Interim Report on 7 May